West, a global manufacturer of components and systems for injectable drug delivery, announced the introduction of Westar RU (ready-to-use) components for cartridge-based injection device applications.
Westar lined seals and plungers are manufactured to meet U.S. Food and Drug Administration and global regulatory requirements for drug packaging components and can help drug manufacturers meet increasing demand for safe, effective self-injection delivery devices. This new product line allows companies to simplify their drug development strategy, streamline manufacturing, and help ensure patient safety by selecting cartridge plungers and lined seals in ready-to-use format.
Growth in both biologics and diabetes markets is driving demand for self-injection drug formats, such as pens that ease administration and ensure patient safety. More pharmaceutical and biotechnology manufacturers are turning to injection devices with prefilled cartridge container closures systems to help patients with chronic conditions that require self-administration of therapeutics to manage their conditions at home. West cartridge components incorporate high-quality lined seals and plungers to reduce the risk of variability and the potential effects on drug quality, safety, and efficacy. In addition, cartridge components are available in Westar RS (ready-to-sterilize) format.
Westar RU components streamline manufacturing operations for pharmaceutical and biotechnology customers. The consistent and predictable quality of steam-sterilized Westar components ensures there will be minimal processing variation during filling and assembly, which can lead to increased throughput in fill-finish lines and less risk of line interventions. Additionally, Westar RU seals, lined seals and plungers have low bioburden, endotoxin, and particulate levels, and may help minimize the risk of recalls due to particulates or sterility assurance issues.